We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · September 02, 2021

Plasma Dabrafenib and Trametinib Concentrations in Advanced BRAFV600-Mutant Melanoma

Annales de Dermatologie et de Venereologie


Additional Info

Annales de Dermatologie et de Venereologie
Monitoring of Plasma Concentrations of Dabrafenib and Trametinib in Advanced BRAFV600mut Melanoma Patients
Ann Dermatol Venereol 2021 Jun 25;[EPub Ahead of Print], M Raynal, JC Alvarez, P Saiag, A Beauchet, C Funck-Brentano, E Funck-Brentano

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading